GSEA analysis also indicated that PUS1 may be involved in DNA_REPAIR, E2F_TARGETS, MYC_TARGETS_V2, G2M_CHECKPOINT, and MYC_TARGETS_V1 pathways, triggering NSCLC malignancy. Here, PUS1 is linked to non-small cell lung carcinoma.